Update on Ranolazine in the Management of Angina

Vascular Health and Risk Management
doi 10.2147/vhrm.s40477
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Successful Use of Ranolazine in a Patient With Vasospastic Angina

Canadian Journal of Cardiology
Cardiovascular MedicineCardiology
2019English

Cost-Effectiveness of Ranolazine for the Treatment of Angina Pectoris in Russia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Ranolazine for Refractory Angina in a Heart Transplant Recipient With Cardiac Allograft Vasculopathy

American Journal of Transplantation
TransplantationAllergyImmunologyPharmacology
2017English

Ranolazine for the Symptomatic Treatment of Patients With Chronic Angina Pectoris in Greece: A Cost-Utility Study

BMC Health Services Research
Health Policy
2015English

Ranolazine and Microvascular Angina by PET in the Emergency Department: Results From a Pilot Randomized Controlled Trial

Clinical Therapeutics
Pharmacology
2017English

Update on the Management of Diabetic Polyneuropathies

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal MedicinePharmacology
2011English

Update on the Surgical Management of Craniopharyngiomas

European Neurological Review
Neurology
2010English

Ranolazine

Nature Reviews Drug Discovery
MedicineDrug DiscoveryPharmacology
2006English

A Novel Mechanism for the Treatment of Angina, Arrhythmias, and Diastolic Dysfunction: Inhibition of Late INa Using Ranolazine

Journal of Cardiovascular Pharmacology
Cardiovascular MedicinePharmacologyCardiology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy